FindTrial
Sign In

Short-Term Androgen Priming Before COS Using Aromatase Inhibitor and hCG During Early-Follicular-Phase GnRH Antagonist Administration - a Randomized Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00286364
Enrollment
Unknown
Registered
2006-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2007-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

We want to investigate if early follicular phase downregulation and androgen priming, by use of GnRH antagonist, aromatase inhibitor and hCG before COH in a short protocol, shows signs of improvement compared to standard short antagonist protocol

Interventions

DRUGDownregulation and androgen priming by use of GnRH antagonist, aromatase inhibitor and hCG before COH

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* Indication and wish for IVF/ICSI treatment * Womens age 20-39 years (both inclusive) * Regular menstrual cycle within normal range * Body Mass Index: 18-30 kg/m2 (both inclusive) * Negative pregnancy test before treatment * A maximum of 3 earlier IVF/ICSI treatments that did not result in pregnancy

Exclusion criteria

* serious systemic disease * Presence of polycystic ovarian syndrome (PCOS) * Earlier poor response with less than 4 mature follicles * Earlier participation in the investigation

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026